Spinocerebellar Ataxia Type 3 Latest Advances

Management of Neurobehavioral Symptoms Associated With Machado-Joseph Disease.

Journal: The primary care companion for CNS disorders

Published: September 12, 2025

m6A modulates RAN translation from CAG repeat expansion RNA.

Journal: Aggregate (Hoboken, N.J.)

Published: August 29, 2025

Dysarthria in Spinocerebellar Ataxia Type 3: Prevalence and Disease Progression.

Journal: Journal of speech, language, and hearing research : JSLHR

Published: August 22, 2025

Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3.

Journal: European journal of medical research

Published: July 03, 2025

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.

Journal: Acta neuropathologica communications

Published: June 24, 2025

Peripheral inflammation in spinocerebellar ataxia type 3: associations with genetic and clinical manifestations.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: June 20, 2025

Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease.

Journal: Cerebellum (London, England)

Published: June 15, 2025

Gut transit and gut microbiome changes occur prior to the onset of motor impairment in a mouse model of Machado-Joseph disease.

Journal: Neurobiology of disease

Published: June 10, 2025

Co-occurrence of Wilson's Disease and Spinocerebellar Ataxia Type 3 in a Chinese Patient.

Journal: Acta neurologica Belgica

Published: June 05, 2025

Deciphering deubiquitinating enzyme Ataxin-3 as an emerging target for cancer intervention.

Journal: International journal of biological macromolecules

Published: May 25, 2025

Cerebello-cortical Inhibition Underlies the Effects of Cerebellar Magnetic Stimulation on Spinocerebellar Ataxia Type 3: A Randomized Controlled Trial.

Journal: Brain stimulation

Published: May 15, 2025

Machado-Joseph disease in Brazil and other South American countries: A systematic Review and Meta-analysis of Prevalence, CAG Repeat Lengths, Age At Onset, and Ancestry.

Journal: Cerebellum (London, England)

Published: May 13, 2025

Filters

Management of Neurobehavioral Symptoms Associated With Machado-Joseph Disease.

Management of Neurobehavioral Symptoms Associated With Machado-Joseph Disease.

m6A modulates RAN translation from CAG repeat expansion RNA.

m6A modulates RAN translation from CAG repeat expansion RNA.

Dysarthria in Spinocerebellar Ataxia Type 3: Prevalence and Disease Progression.

Dysarthria in Spinocerebellar Ataxia Type 3: Prevalence and Disease Progression.

Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3.

Dysphagia linked to clinical phenotype and disease progression in spinocerebellar ataxia type 3.

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.

Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesis.

Peripheral inflammation in spinocerebellar ataxia type 3: associations with genetic and clinical manifestations.

Peripheral inflammation in spinocerebellar ataxia type 3: associations with genetic and clinical manifestations.

Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease.

Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease.

Gut transit and gut microbiome changes occur prior to the onset of motor impairment in a mouse model of Machado-Joseph disease.

Gut transit and gut microbiome changes occur prior to the onset of motor impairment in a mouse model of Machado-Joseph disease.

Co-occurrence of Wilson's Disease and Spinocerebellar Ataxia Type 3 in a Chinese Patient.

Co-occurrence of Wilson's Disease and Spinocerebellar Ataxia Type 3 in a Chinese Patient.

Deciphering deubiquitinating enzyme Ataxin-3 as an emerging target for cancer intervention.

Deciphering deubiquitinating enzyme Ataxin-3 as an emerging target for cancer intervention.

Cerebello-cortical Inhibition Underlies the Effects of Cerebellar Magnetic Stimulation on Spinocerebellar Ataxia Type 3: A Randomized Controlled Trial.

Cerebello-cortical Inhibition Underlies the Effects of Cerebellar Magnetic Stimulation on Spinocerebellar Ataxia Type 3: A Randomized Controlled Trial.

Machado-Joseph disease in Brazil and other South American countries: A systematic Review and Meta-analysis of Prevalence, CAG Repeat Lengths, Age At Onset, and Ancestry.

Machado-Joseph disease in Brazil and other South American countries: A systematic Review and Meta-analysis of Prevalence, CAG Repeat Lengths, Age At Onset, and Ancestry.